| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edwards Lifesciences Corporation (EW) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. EW is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 215.9K | $18.54M | - | |
| VP | 98.6K | $8.47M | -23,145 | |
| CFO | 46.7K | $4.01M | - | |
| VP | 44.3K | $3.81M | - | |
| VP | 40.4K | $3.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | Lippis Daniel J.62 | Cvp, Japac | Sale+OE | 857 | $92.34 | $79,135.38 | -4.7% | -1.3% | -24.9% | |
| Apr 8, 2024 | Lemercier Jean-Luc M67 | Cvp, Emeacla | Sale+OE | 14,400 | $92.32 | $1,329,471.90 | -3.8% | -0.5% | -27.4% | |
| Apr 8, 2024 | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sale+OE | 12,500 | $92.33 | $1,154,141.88 | -12.0% | -0.5% | -27.4% | |
| Apr 4, 2024 | Mussallem Michael A65 | Director | Sale+OE | 29,350 | $92.42 | $2,712,418.04 | -24.6% | -0.1% | -23.9% | |
| Apr 1, 2024 | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sale+OE | 7,255 | $94.89 | $688,423.49 | -14.0% | -4.2% | -23.7% | |
| Mar 13, 2024 | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sale+OE | 14,500 | $91.01 | $1,319,695.75 | -26.9% | -6.4% | -26.9% | |
| Mar 11, 2024 | Lemercier Jean-Luc M67 | Cvp, Emeacla And Japac | Sale+OE | 14,400 | $91.68 | $1,320,148.80 | -7.7% | -5.2% | -24.7% | |
| Mar 7, 2024 | Lippis Daniel J.62 | Cvp, Japac | Sale+OE | 1,715 | $90.98 | $156,030.70 | -9.1% | -7.2% | -25.0% | |
| Mar 4, 2024 | Mussallem Michael A65 | Director | Sale+OE | 29,350 | $86.67 | $2,543,737.10 | -54.0% | +1.0% | -18.0% | |
| Feb 29, 2024 | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sale+OE | 7,255 | $85.59 | $620,922.80 | -27.6% | +2.5% | -15.6% |